Perspective Therapeutics (CATX) Other Operating Expenses (2010 - 2024)

Perspective Therapeutics has disclosed Other Operating Expenses across 15 years of filings, most recently posting -$27000.0 for Q4 2024.

• Other Operating Expenses for Q4 2024 came in at -$27000.0, down 222.73% year-over-year; the trailing twelve-month figure through Sep 2025 was -$27000.0 (down 222.73% YoY), and the FY2024 annual result was -$27000.0, changed N/A from the prior year.
• Other Operating Expenses came in at -$27000.0 for Q4 2024 at Perspective Therapeutics, down from $22000.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $1.6 million in Q1 2022 to a low of -$7.9 million in Q3 2022.
• The 5-year median for Other Operating Expenses is -$2000.0 (2021), against an average of -$699153.8.
• Across the five-year window, Other Operating Expenses soared 80400.0% in 2020 and plunged 1134.3% in 2022, its largest moves.
• Perspective Therapeutics' Other Operating Expenses stood at -$7000.0 in 2020, then soared by 10971.43% to $761000.0 in 2021, then plunged by 140.08% to -$305000.0 in 2022, then soared by 107.21% to $22000.0 in 2023, then slumped by 222.73% to -$27000.0 in 2024.
• The last three Other Operating Expenses figures came in at -$27000.0 (Q4 2024), $22000.0 (Q4 2023), and -$22000.0 (Q1 2023), per Business Quant data.